Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.02 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.03 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |